Literature DB >> 18809225

Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study.

Kwang-Ho In1, Yong-Soo Kwon, In-Jae Oh, Kyu-Sik Kim, Maan-Hong Jung, Kwan-Ho Lee, Sun-Young Kim, Jeong-Seon Ryu, Sung-Yong Lee, Eun-Taik Jeong, Sang-Yeub Lee, Ho-Kee Yum, Chang-Geol Lee, Woo-Sung Kim, Jae-Ill Zo, Hojoong Kim, Young-Whan Kim, Se-Kyu Kim, Jae-Cheol Lee, Young-Chul Kim.   

Abstract

PURPOSE AND METHODS: The outcomes of lung cancer patients who were asymptomatic at diagnosis have never been reported as part of a large-scale study. A national survey of lung cancer in South Korea registered a total of 8788 patients diagnosed in 2005. We report the results herein, with an emphasis on the prognosis of the asymptomatic lung cancer patients.
RESULTS: Adenocarcinoma was the most frequent (36.1%) histopathologic type, followed by squamous cell carcinoma (32.1%), large cell carcinoma (1.5%), and small cell carcinoma (13.5%). In most cases, lung cancer was detected with subjective symptoms, but 6.5% of cases had no symptoms indicative of lung cancer at the time of diagnosis. Compared to symptomatic patients, asymptomatic patients were younger, more often female, non-smokers, and more frequently presented with adenocarcinoma. Initial treatments were surgery (22.1%), radiation therapy (7.8%), chemo-radiation therapy (5.4%), and chemotherapy (38%), while 26.6% of patients were recorded to have supportive care only. Asymptomatic patients received surgery in 60.0% of cases, and they showed significantly longer survival times than symptomatic patients. Absence of symptoms at diagnosis significantly reduced the risk of death from non-small cell lung cancer, regardless of patient age, patient gender, stage at diagnosis, smoking history, or whether treatment was performed, but did not reduce the risk of death from small cell lung cancer.
CONCLUSIONS: Adenocarcinoma has grown to be the leading histopathologic type of lung cancer in South Korea. Absence of symptom at diagnosis is a favorable prognostic factor for patients with non-small cell lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18809225     DOI: 10.1016/j.lungcan.2008.08.005

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  20 in total

1.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

2.  Progastrin-releasing peptide as a diagnostic and therapeutic biomarker of small cell lung cancer.

Authors:  Hyung-Joo Oh; Ha-Young Park; Ki-Hyun Kim; Cheol-Kyu Park; Hong-Joon Shin; Jung-Hwan Lim; Yong-Soo Kwon; In-Jae Oh; Yu-Il Kim; Sung-Chul Lim; Young-Chul Kim; Soo-Hyun Kim; Myung-Geun Shin
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  Variability in the anti-tumor effect of tegafur-uracil depending on histologic types of lung cancer.

Authors:  Bo-Ram Lee; Jin-Yeong Yu; Seong-Hoon Yoon; Hee-Jung Ban; Yong-Soo Kwon; In-Jae Oh; Kyu-Sik Kim; Yu-Il Kim; Sung-Chul Lim; Young-Chul Kim
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

4.  Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer.

Authors:  Sun Kim; In-Jae Oh; Seo-Yeon Park; Jang-Hyeon Song; Hyun-Ju Seon; Yun-Hyeon Kim; Seong-Hoon Yoon; Jin-Yeong Yu; Bo-Ram Lee; Kyu-Sik Kim; Young-Chul Kim
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

5.  TP53 mutations in Korean patients with non-small cell lung cancer.

Authors:  Eung Bae Lee; Guang Jin; Shin Yup Lee; Ji Young Park; Min Jung Kim; Jin Eun Choi; Hyo Sung Jeon; Seung Ick Cha; Sukki Cho; Chang Ho Kim; Tae-In Park; Tae Hoon Jung; Ji-Woong Son; Jae Yong Park
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

6.  Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer.

Authors:  In-Jae Oh; Hye-Eun Kim; Sang-Yun Song; Kook-Joo Na; Kyu-Sik Kim; Young-Chul Kim; Seung-Won Lee
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

7.  Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population.

Authors:  Sang-Yong Eom; Dong-Hyuk Yim; Chul-Ho Lee; Kang-Hyeon Choe; Jin Young An; Kye Young Lee; Yong-Dae Kim; Heon Kim
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

8.  Clinical characteristics and prognosis of incidentally detected lung cancers.

Authors:  S Quadrelli; G Lyons; H Colt; D Chimondeguy; A Buero
Journal:  Int J Surg Oncol       Date:  2015-02-03

9.  Pathway-based analysis using genome-wide association data from a Korean non-small cell lung cancer study.

Authors:  Donghoon Lee; Geon Kook Lee; Kyong-Ah Yoon; Jin Soo Lee
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

Review 10.  Epidemiology of Lung Cancer in Korea: Recent Trends.

Authors:  Ji Young Park; Seung Hun Jang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.